JPS6490197A - Peptide - Google Patents

Peptide

Info

Publication number
JPS6490197A
JPS6490197A JP24695287A JP24695287A JPS6490197A JP S6490197 A JPS6490197 A JP S6490197A JP 24695287 A JP24695287 A JP 24695287A JP 24695287 A JP24695287 A JP 24695287A JP S6490197 A JPS6490197 A JP S6490197A
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid sequence
type hepatitis
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP24695287A
Other languages
Japanese (ja)
Inventor
Shigetada Nakanishi
Toshio Shikata
Isao Ono
Yoko Shimizu
Yoshikazu Honda
Toshiro Maeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP24695287A priority Critical patent/JPS6490197A/en
Publication of JPS6490197A publication Critical patent/JPS6490197A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NEW MATERIAL:A peptide, specifically reactive with a non-A, non-B type hepatitis antigen mouse monoclonal antibody and having an amino acid sequence expressed by the formula or partial sequence thereof. USE:A diagnostic reagent and vaccine for non-A, non-B type hepatitis for screening transfusion blood or blood pharmaceuticals. PREPARATION:For example, analysis of hydrophilicity and prediction of secondary structure of antigenic protein are carried out on the basis of an amino acid sequence found from the base sequence of a gene capable of coding a non-A, non-B type hepatitis antigen to estimate a part which is a hydrophilic region for determining antigenicity on an antigenic protein from a part of a secondary structure, such as alpha-helix or turn. A peptide constituting the estimated part for determining the antigenicity is then synthesized by using an automatic synthetic apparatus for the peptide by a conventional method to afford the aimed peptide having the amino acid sequence expressed by the formula or partial sequence thereof.
JP24695287A 1987-09-30 1987-09-30 Peptide Pending JPS6490197A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24695287A JPS6490197A (en) 1987-09-30 1987-09-30 Peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24695287A JPS6490197A (en) 1987-09-30 1987-09-30 Peptide

Publications (1)

Publication Number Publication Date
JPS6490197A true JPS6490197A (en) 1989-04-06

Family

ID=17156175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24695287A Pending JPS6490197A (en) 1987-09-30 1987-09-30 Peptide

Country Status (1)

Country Link
JP (1) JPS6490197A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017493A2 (en) * 1991-04-05 1992-10-15 Biochem Pharma Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
WO1992017493A2 (en) * 1991-04-05 1992-10-15 Biochem Pharma Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
WO1992017493A3 (en) * 1991-04-05 1992-12-10 Iaf Biochem Int Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)

Similar Documents

Publication Publication Date Title
KR900701836A (en) Peptides useful for diagnosing, preventing or treating new HIV proteins and AIDS
EP1308507B1 (en) HCV anti-core monoclonal antibody
UA42668C2 (en) POLYPEPTIDE, WHICH HAS THE ANTIGENIC PROPERTIES OF THE VIRUS OF HEPATITE S (HCV) (VARIANTS), DIAGNOSTIC REAGENT DL4 To THE VIRUS OF HEPATITE S (VARIANTS), COLLECTION FOR THE DEVELOPMENT OF ANTIBODIES To THE VIRUS OF HEPATITE S (VARIANTS), METHOD OF THE DEVELOPMENT OF ANTIBODIES To THE VIRUS OF HEPATITE S (VARIANTS)
SE8704185L (en) NEW PEPTIDES, ARTIFICIAL ANTIGENS AND IMMUNO ANALYSIS TEST RATES
ZA912305B (en) Novel vaccine
WO1992010514A3 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
KR20010042807A (en) Improved immunodiagnostic assays using reducing agents
HK1014012A1 (en) Liver-stage-speciic peptide sequences of-i (p.falciparum) bearing epitopes capable of stimulating the t lymphocytes
KR940703851A (en) Hepatitis E Virus Peptide Antigen and Antibody (HEPATITIS E VIRUS PEPTIDE ANTIGENS AND ANTIBODIES)
CA2391356A1 (en) Peptides designed for the diagnosis and treatment of rheumatoid arthritis
CA2499926A1 (en) Antibody against von willebrand factor cleaving enzyme and assay system using the same
EP0411938A3 (en) Radio-immuno assay for hepatitis b virus pres2 antibodies
DE3887750D1 (en) SELECTIVE REMOVAL OF IMMUNE COMPLEXES.
EP0662082A1 (en) Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis
ATE189683T1 (en) HCV PEPTIDE ANTIGENS AND METHODS FOR DETERMINING HCV
JPS6490197A (en) Peptide
EP0293827A3 (en) Assay for leishmaniasis
DE69836647D1 (en) METHOD FOR THE PRODUCTION OF (POLY) PEPTIDES USING CONCRETE VARIANTS OF SV40 'LARGE' T ANTIGEN WITH AN INTACT N TERMINUS
EP0595638B1 (en) Epitope-related peptides of human parvovirus
US5885771A (en) Antigenic peptide compound and immunoassay
KR970705578A (en) NEW IMMUNOCONTRACEPTIVE PEPTIDES (NEW IMMUNOCONTRACEPTIVE PEPTIDES)
EP0620231A1 (en) Human parvovirus B19 epitope-related peptide
CN101928333A (en) Human EIF4H polypeptide and preparation method of antibody thereof
SE8901566D0 (en) NEW PEPTIDES INCLUDING A DISULFID BOND